--- title: "Pre-market hot trades in US stocks: Arm up 5.76% in pre-market; Coinbase down 5.31% in pre-market" type: "News" locale: "en" url: "https://longbridge.com/en/news/294494513.md" description: "Arm pre-market rose 5.76%; Coinbase pre-market fell 5.31%; Microbus pre-market rose 203.33%; Replimune pre-market rose 132.35%; K Wave Media pre-market rose 116.71%" datetime: "2026-07-31T10:08:17.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/294494513.md) - [en](https://longbridge.com/en/news/294494513.md) - [zh-HK](https://longbridge.com/zh-HK/news/294494513.md) --- # Pre-market hot trades in US stocks: Arm up 5.76% in pre-market; Coinbase down 5.31% in pre-market **Pre-market Hot Trades in US Stocks** Arm is up 5.76% in pre-market trading. Based on recent key news: 1. On July 30, Arm announced its Q1 FY2027 financial report, with revenue of $1.29 billion, a 22% year-on-year increase, exceeding market expectations. The company expects Q2 revenue to be between $1.33 billion and $1.43 billion, with analysts estimating $1.35 billion. This news drove the stock price up in pre-market trading. Source: Guandian.com 2. On July 30, Arm stated in an analyst conference call that despite a weak smartphone market, strong growth in cloud AI and licensing business helps offset the impact. This news led to a 5.73% drop in the stock price after hours. Source: Zhitong Finance 3. On July 30, Citigroup analysts pointed out that Arm's cloud AI and licensing business is growing strongly, maintaining a "Buy" rating with a target price of $300. This analyst's view has a positive impact on market confidence. Source: Citigroup report on the semiconductor industry facing demand uncertainty and increased volatility. Coinbase is down 5.31% in pre-market trading. Based on recent key news: 1. On July 31, Coinbase announced its Q2 financial report, with revenue down 19% year-on-year and a net loss of $359 million, leading to a 5.3% drop in the stock price after hours. The report showed that trading revenue fell 21% year-on-year to $599 million. Source: Zhitong Finance 2. On July 31, the continued slump in the cryptocurrency market led to a decline in Coinbase's trading volume, causing a 5.3% drop in the stock price after hours. Macroeconomic factors such as uncertainty in the US interest rate outlook and geopolitical tensions have affected investors' risk appetite. Source: Jinse Finance 3. On July 31, although Coinbase's subscription and service revenue increased, it was not enough to fully offset the volatility in trading business, leading to a drop of about 7% in the stock price after hours. The company stated that its diversification strategy is showing results, but the overall market environment remains weak. Source: Jinse Finance, with the cryptocurrency market sluggish and macroeconomic uncertainty increasing. **Top Gainers in Pre-market US Stocks** WeBus is up 203.33% in pre-market trading. Based on recent key news: 1. On July 30, Wetour Robotics announced a stock consolidation plan with a consolidation ratio of 1 to 100, expected to take effect on August 3. This move may lead to a reassessment of its stock by the market, affecting stock price volatility. Source: SEC announcement 2. On July 29, Fermi and Galaxy Digital face challenges amid changes in cryptocurrency regulation, with investors' interest in risk assets fluctuating. Such macroeconomic factors may affect the market performance of related stocks. Source: MarketWatch 3. On July 29, the performance of Teucrium Wheat Fund and Sprott Physical Silver Trust reflects geopolitical supply shocks and inflation expectations, which may influence investors' investment strategies in traditional commodities Source: Bloomberg The impact of cryptocurrency regulatory changes on market sentiment. Replimune pre-market up 132.35%. Based on recent key news: 1. On July 30, the FDA's Cellular, Tissue, and Gene Therapies Advisory Committee gave a positive evaluation of Replimune's RP1 drug for advanced melanoma. This news significantly boosted Replimune's stock price. 2. On July 28, FDA reviewers expressed concerns about the efficacy of Replimune's RP1 drug, leading to a pre-market drop of 22.6% in the company's stock price. 3. On July 29, BMO analysts pointed out concerns from the FDA regarding the contribution of RP1 drug components and the heterogeneity of the treatment population, causing the stock price to drop 33.26% during trading. The biopharmaceutical industry faces regulatory challenges, increasing market volatility. K Wave Media pre-market up 116.71%. Based on recent key news: 1. On July 30, K Wave Media announced a 1-for-30 reverse stock split. This move aims to meet Nasdaq's minimum bid requirements and is expected to take effect on August 3. The reverse split will reduce the number of shares outstanding, thereby increasing the price per share. 2. On July 30, K Wave Media plans to trade on Nasdaq at the adjusted price. This move will make the company's stock more attractive in the market and may attract more investor attention. 3. On July 30, K Wave Media's announcement drew market attention, with investors holding an optimistic view of the company's future development, driving a significant increase in stock price. The market reacted positively to the reverse split, with attention to liquidity risks ### Related Stocks - [ARM.US](https://longbridge.com/en/quote/ARM.US.md) - [COIN.US](https://longbridge.com/en/quote/COIN.US.md) - [WETO.US](https://longbridge.com/en/quote/WETO.US.md) - [REPL.US](https://longbridge.com/en/quote/REPL.US.md) - [KWM.US](https://longbridge.com/en/quote/KWM.US.md) ## Related News & Research - [Arm’s Biggest Opportunity Comes With Its Biggest Risk](https://longbridge.com/en/news/294403886.md) - [Dear Arm Stock Fans, Mark Your Calendars for July 29](https://longbridge.com/en/news/294092734.md) - [Arm Just Scored a Major Server Market Share Win. What That Means for ARM Stock Here.](https://longbridge.com/en/news/293824262.md) - [ARM (NASDAQ:ARM) Posts Earnings Results, Beats Estimates By $0.05 EPS](https://longbridge.com/en/news/294265131.md) - [Arm posts shareholder letter for fiscal Q1 2027 results on investor relations website](https://longbridge.com/en/news/294253854.md)